Nutriband

IPO

Advancing Transdermal Technologies for Patient Safety

Public · Orlando, United States

Headquarters
Orlando, Florida
Type
Public
Ticker
NTRB · NASDAQ

About

Nutriband is a values-based company rooted in science and innovation, working to transform new ideas into safer products for patients. Its lead product is AVERSA, an abuse-deterrent transdermal technology that incorporates aversive agents to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential, specifically opioids. The company's first application of AVERSA is an abuse-deterrent fentanyl transdermal patch, currently in development to give clinicians and patients an extended-release option for chronic pain relief.

Summary

Nutriband is a Drug Discovery company based in Orlando, United States.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nutriband on Indexed.vc
<a href="https://indexed.vc/companies/nutriband"><img src="https://indexed.vc/api/badge/company/nutriband" alt="Nutriband on Indexed.vc" width="260" height="76" /></a>